Legal status in the United States

Is Low-Dose Naltrexone legal?

Read at FDA, DEA and WADAPublished by PepVault

Low-Dose Naltrexone is FDA-approved (Revia and Naltrexone hydrochloride (generic), first in 1984), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 19, 2026.

Low-Dose Naltrexone at a glance

CheckStatus, read Nov 19, 2026
FDA approvalApproved (Revia, 1984)
CompoundingNot checked yet
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Naltrexone hydrochloride is FDA-approved, first as Revia tablets in 1984, at 50 mg for alcohol dependence and to block the effects of opioids. Drugs@FDA lists that Revia application as discontinued; generic naltrexone tablets are sold today under later applications. No low-dose product is approved: the 1 to 6 mg doses are off-label, usually made up by a compounding pharmacy.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Not checked yet. We could not settle this at its primary source on November 19, 2026, so the page leaves it out rather than guess.

DEA schedule

It is not a federally controlled substance: the DEA’s Schedule II names it only to exclude it, among the opiate derivatives (21 CFR 1308.12), and it is not on the DEA’s alphabetical list of controlled substances.

The source: “naloxegol, naloxone, 6β-naltrexol, naltrexone, and samidorphan”

Sport (WADA)

WADA’s 2026 Prohibited List doesn’t name naltrexone, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.

What this means and doesn’t

This page reports what the agencies’ own pages said about Low-Dose Naltrexone in the United States when we read them on November 19, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Low-Dose Naltrexone FDA approved?

    Naltrexone hydrochloride is FDA-approved, first as Revia tablets in 1984, at 50 mg for alcohol dependence and to block the effects of opioids. Drugs@FDA lists that Revia application as discontinued; generic naltrexone tablets are sold today under later applications. No low-dose product is approved: the 1 to 6 mg doses are off-label, usually made up by a compounding pharmacy.

  • Is Low-Dose Naltrexone a controlled substance?

    It is not a federally controlled substance: the DEA’s Schedule II names it only to exclude it, among the opiate derivatives (21 CFR 1308.12), and it is not on the DEA’s alphabetical list of controlled substances.

  • Is Low-Dose Naltrexone banned in sport?

    WADA’s 2026 Prohibited List doesn’t name naltrexone, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo